Higgins, Peter D.R. M.D., Ph.D.; Johanson, John F. M.D., M.Sc.
Department of Internal Medicine, University of Michigan Division of Gastroenterology, Ann Arbor, Michigan; and Rockford Gastroenterology Associates, Rockford, Illinois
Dr. Higgins is supported by the NIH T32 Training Grant in Gastroenterology Outcomes Research at the University of Michigan. This research was also supported by an unrestricted educational grant from Novartis Pharmaceuticals Corporation.
Dr. Johanson is on the Speaker's Bureau for Novartis Pharmaceuticals Corporation, AstraZeneca, Janssen Pharmaceuticals, and Wyeth Ayerst. Dr. Johanson is a consultant to Novartis Pharmaceuticals Corporation, Sucampo Pharmaceuticals, GlaxoSmithKline and Symbio.
Reprint requests and correspondence: John F. Johanson, M.D., M.Sc., Rockford Gastroenterology Associates, Ltd., 401 Roxbury Road, Rockford, IL 61107.
Received July 24, 2003; accepted December 2, 2003.